https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Australian pharmaceutical policy and the idea of innovation. https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:4569 Wed 11 Apr 2018 16:57:52 AEST ]]> A prompt to the web: the media and health information seeking behaviour https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21738 Wed 11 Apr 2018 16:30:17 AEST ]]> An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect? https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:15671 Wed 11 Apr 2018 14:48:42 AEST ]]> Potency, hubris, and susceptibility: the disease mongering critique of pharmaceutical marketing https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19794 Wed 11 Apr 2018 13:22:50 AEST ]]> Disease mongering is now part of the global health debate https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:4458 Wed 11 Apr 2018 12:44:10 AEST ]]> Nurses' recognition and response to unsafe practice by their peers: A qualitative descriptive analysis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51857 Thu 21 Sep 2023 09:41:13 AEST ]]> Nurses’ perspectives of recognising and responding to unsafe practice by their peers: A national cross-sectional survey https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49322 Thu 11 May 2023 15:00:33 AEST ]]> Australia's pharmaceutical cost sharing policy: reducing waste or affordability ? https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7008 Sat 24 Mar 2018 08:37:49 AEDT ]]> Moral hazard and prescription medicine use in Australia: the patient perspective https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:1750 Sat 24 Mar 2018 08:27:28 AEDT ]]> Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:2260 US $382; odds ratio [OR], 3.5; 95% confidence interval [CI], 2.6-4.7) and support for attending international conferences (OR, 5.4; 95% CI, 3.9-7.4). The strongest associations were seen for acting as a paid consultant to industry (OR, 9.0; 95% CI, 3.9-20.4) and for membership on advisory boards (OR, 6.9; 95% CI, 5.1-9.6). There was a strong relationship between research collaboration and accumulation of industry ties. For 1 additional tie the OR was 2.2 (95% CI, 1.2-3.8) and rose to 6.3 (95% CI, 3.5-11.1) with 3 ties and 41.8 (95% CI, 14.5-143.4) with 6 or more ties. Conclusions: Medical specialists who have research relationships with the pharmaceutical industry are much more likely to have multiple additional ties than those who do not have research relationships. Institutional review should discourage clinical researchers from developing multiple ties.]]> Sat 24 Mar 2018 08:27:17 AEDT ]]> Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:10528 Sat 24 Mar 2018 08:13:58 AEDT ]]> The affordability of prescription medicines in Australia: are copayments and safety net thresholds too high?. https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:16491 Sat 24 Mar 2018 08:05:37 AEDT ]]> Pharmaceutical Benefits Scheme cost sharing, patient cost consciousness and prescription affordability https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:16505 Sat 24 Mar 2018 08:04:17 AEDT ]]> Prescription medicines: decision-making preferences of patients who receive different levels of public subsidy https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19176 Sat 24 Mar 2018 07:52:18 AEDT ]]> Moral hazard and prescription medicine use in Australia - the patient perspective https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:138 Sat 24 Mar 2018 07:43:13 AEDT ]]> Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:213 Sat 24 Mar 2018 07:43:08 AEDT ]]> Part of the fabric and mostly right: an ethnography of ethics in clinical practice https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28886 Sat 24 Mar 2018 07:40:30 AEDT ]]> Drug promotion in Australia: policy contestation and the tightening of regulation https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28755 Sat 24 Mar 2018 07:37:34 AEDT ]]> Australian pharmaceutical policy: price control, equity, and drug innovation in Australia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:4758 Sat 24 Mar 2018 07:21:08 AEDT ]]> Mixed method integrative review exploring nurses' recognition and response to unsafe practice https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:24074 Sat 24 Mar 2018 07:09:40 AEDT ]]>